Press release
Rise In FDA Approved Facilities To Drive Demand For Pharmaceutical Contract Manufacturing
The publication is titled, “Global Pharmaceutical Contract Manufacturing Market 2016-2020.” The study examines the trends and the growth trail of the global pharmaceutical contract manufacturing market. It further highpoints the dynamics have been expected to influence the development of the market in the near future. A brief outlook has also been provided in the research study regarding the key participant in the global pharmaceutical contract manufacturing market and their shares, product range, and key strategies.According to the report, the global market for pharmaceutical contract manufacturing is projected to witness a 7% CAGR from 2016 to 2020. The global market for pharmaceutical contract manufacturing is likely to have an optimistic outlook in the coming years owing to the rising number of manufacturing facilities approved by the U.S. FDA. During the time of choosing a partner for the purpose of outsourcing, the pharmaceutical companies search for the plants which have been approved by the U.S. FDA along with low operating cost and a skilled workforce. For instance, India has above 100 US FDA permitted manufacturing units and is also one of the most preferred locations for outsourcing manufacturing services. Furthermore, the execution of WTO TRIPS-mandated product patents has directed to an increase in outsourcing in the mature markets.
The technological advancements and innovations in vaccinations and medical sciences coupled with developments in stem cell research and nanotechnology, are aiding in the expansion of pharmaceutical product ranges, thus including drugs with a short shelf life. This, in turn, is triggering the manufacturing and distribution process. Various pharmaceutical companies such as GSK, Johnson & Johnson, and Pfizer CentreOne are investing on research and development projects in order to introduce new and innovative medicines for several different diseases.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/867642
Based on type, the global pharmaceutical contract manufacturing market has been segmented into final dosage form and API/bulk drug manufacturing. In 2015, the segment of API/bulk drug manufacturing dominated the market and is anticipated to retain a leading position until 2020. One of the chief factors fueling this segment’s growth is the upsurge in the number of drug approvals. In terms of geography, the global pharmaceutical contract manufacturing market is classified into Asia Pacific, the Americas, and Europe and the Middle East and Africa. The Americas generated the maximum revenue and is expected to do the same over the coming years owing to the rising demand for generics and initiatives taken up by governments. Some of the key players in the market are Catalent, Lonza, Pfizer CentreOne, Apotex, Gedeon Richter, and Biogen.
To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz
MarketResearchReports.biz supports your business intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market data sheets in its repository. Our document database is updated by the hour, which means that you always have access to fresh data spanning over 300 industries and their sub-segments.
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
(USA-CANADA)
Tel: +1-518-621-2074
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rise In FDA Approved Facilities To Drive Demand For Pharmaceutical Contract Manufacturing here
News-ID: 436901 • Views: …
More Releases from MarketResearchReports.biz

Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…

Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…

Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…

Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for FDA
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…